MAR 19, 2018 9:08 PM PDT

Menopausal Hot Flashes: Potential Treatment

WRITTEN BY: Nouran Amin

Menopause is defined as the time in a female’s life (usually from 45 to 55 years of age) where the monthly menstrual cycle no longer continues, and conception is not possible. It's caused by a drop in estrogen levels involving symptoms menopausal flushing and sweating.

In many women, the experience of hot flushes can be irritable and uncomfortable, and for others, it can be as severe as clothes drenched in sweat. These hot flushes can impair a women’s everyday functions from social life to working. However, a class of experimental drugs seeks to relieve women suffering from menopausal symptoms and provide a potential treatment option besides hormonal replacement therapy.

These drugs were tested by scientists at Imperial College London which showed a one-third reduction of hot flushes in as little as three days. The experimental compounds were examined in a clinical trial and results were recently published in the journal Menopause.

Image via Medical News Today

Clinical trial participants received a drug called ‘MLE4901’ which was found to reduce the number and severity of flashes across a four-week period. MLE4901 also improved sleep conditions. "We already knew this compound could be a game-changer for menopausal women and get rid of three-quarters of their hot flushes in four weeks. But this new analysis confirms the beneficial effect is obtained very quickly -- within just three days," says Professor Waljit Dhillo, a NIHR Research Professor from the Department of Medicine at Imperial College of London.

Although the compound has had great results, it nevertheless comes with side effects; it may affect liver function. This leads to MLE4901 not progressing to further clinical trials. Yet, two other drugs similar to the role of MLE4901, inhibit NKB (a neurochemical) but do not seem to affect liver function. This launched another clinical trial.

The inhibition of NKB is believed to control temperature fluxes, the actions of NKB is what triggers hot flushes in rodent models. Therefore, the experimental drugs are thought to prevent NKB activating temperature control areas that essentially place a stop on hot flushes. Recent results also showed that the experimental drug was not only capable of controlling nighttime hot flashes but even during the day. But, regardless, lead researchers believe more data is needed to study if the drug is involved in pathways that improve sleep and concentration, or if these two factors were dependent on hot flushes. The first author of the study, Dr. Julia Prague, states. “As NKB has many targets of action within the brain the potential for this drug class to really improve many of the symptoms of the menopause, such as hot flushes, difficulty sleeping, weight gain, and poor concentration, is huge. To see the lives of our participants change so dramatically and so quickly was so exciting, and suggests great promise for the future of this new type of treatment."

The goal of these compounds is to relieve symptoms of menopause and provide a different route for treatment. The is important because current menopausal symptom treatment involves a therapy known as “Hormonal Replacement”. This particular therapy is proven to be ineffective because of the accumulated significant side effects, including increasing the risk of breast cancer and blood clot formation.

Sources: Menopause, Women’s Health

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
AUG 16, 2020
Cannabis Sciences
Cannabinoids May Interact with Prescribed Medications
AUG 16, 2020
Cannabinoids May Interact with Prescribed Medications
Despite the growing popularity of cannabis products, information is currently limited on how they may interact with othe ...
AUG 21, 2020
Immunology
Cancer Feels the STING
AUG 21, 2020
Cancer Feels the STING
Researchers have discovered a protein that can amplify immune reactions against tumors. The stimulator of interferon gen ...
SEP 08, 2020
Cardiology
Fixing Stem Cell Therapy for Heart Repair
SEP 08, 2020
Fixing Stem Cell Therapy for Heart Repair
Repairing the damage done by a heart attack has been of keen interest for decades. Some researchers think protecting the ...
SEP 11, 2020
Drug Discovery & Development
Single Injection Sends Type 2 Diabetes into Remission
SEP 11, 2020
Single Injection Sends Type 2 Diabetes into Remission
Type 2 diabetes affects around 10% of people in the US. Although there is no cure for it, there are some well-known meth ...
OCT 01, 2020
Immunology
Immune Cells and MS: The Good, the Bad, and the Maybe
OCT 01, 2020
Immune Cells and MS: The Good, the Bad, and the Maybe
Much like electrical wires that are encased in plastic insulating sheaths, nerve cells also are also surrounded by a sim ...
OCT 06, 2020
Drug Discovery & Development
New Immunotherapy Drug Effective Against Lung Cancer
OCT 06, 2020
New Immunotherapy Drug Effective Against Lung Cancer
A new study has confirmed that Tecentriq, an immunotherapy drug, improves survival rates among those with newly diagnose ...
Loading Comments...